Form 4: Healthcare Services Group Director Receives Deferred Stock Unit Grant

Thomas Gerard Whalen, a Director at Healthcare Services Group Inc. (HCSG), was granted 2,806 unvested deferred stock units on May 27, 2025, as part of his compensation.

Summary

• On May 27, 2025, Thomas Gerard Whalen, a Director of Healthcare Services Group Inc. (HCSG), acquired 2,806 shares of common stock in the form of unvested deferred stock units (DSUs).
• The DSUs were granted at a price of $14.26 per unit.
• These DSUs will become fully vested on the one-year anniversary of the grant date.
• Settlement of the DSUs into shares of common stock will occur on the earliest of: the five-year anniversary of the grant date, the participant's date of death, disability, or separation from service, or the date of a Change of Control.
• Following this transaction, Mr. Whalen beneficially owns 2,806 unvested DSUs and 0 vested DSUs.

Sentiment

Score: 6

Explanation: The grant of deferred stock units to a director is a standard compensation practice that aligns the director's interests with the company's long-term performance, which is generally viewed as a positive or neutral event for shareholders.

Positives

• The grant of deferred stock units aligns the director's long-term interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a standard form of non-cash compensation for directors, indicating a structured approach to governance and incentivization.

Future Outlook

The deferred stock units granted to the director are set to vest on the one-year anniversary of the grant date and will be settled in common stock on the earliest of the five-year anniversary of the grant date, the participant's death, disability, separation from service, or a change of control.

Industry Context

The grant of deferred stock units to a director is a common practice across various industries, including healthcare services, as a means of non-cash compensation. This method helps retain experienced board members and aligns their financial incentives with the long-term performance and strategic goals of the company.

Comparison to Industry Standards

• The use of Deferred Stock Units (DSUs) for director compensation is a widely adopted practice among publicly traded companies, including those in the healthcare services sector, such as Aramark (ARMK) or Compass Group (CPG.L), which often utilize similar equity-based incentives to align director interests with shareholder value.
• The vesting schedule (one-year anniversary) and settlement triggers (five-year anniversary, death, disability, separation, change of control) are typical for such grants, reflecting standard corporate governance practices aimed at long-term retention and performance alignment.

Related Party Transactions

• The transaction involves the grant of deferred stock units from Healthcare Services Group Inc. to Thomas Gerard Whalen, a Director of the company, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The grant of DSUs to a director can be seen as a positive step towards aligning management and board interests with long-term shareholder value, potentially leading to more sustainable growth strategies.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Vesting of the 2,806 deferred stock units on the one-year anniversary of the grant date (May 27, 2026).
• Settlement of the deferred stock units into common stock on the earliest of the five-year anniversary of the grant date, the participant's death, disability, separation from service, or a change of control.

Key Dates

Recommendation

Keywords

Healthcare Services Group, HCSG, Form 4, SEC filing, insider transaction, deferred stock units, DSU, director compensation, equity grant, common stock